Synthetic organic

Potent DYRK1B inhibitor.

Potent DYRK1B inhibitor.

Potent DYRK1B inhibitor.

Potent DYRK1B inhibitor.

AZ3146 is a potent and selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 35 nM): less potent to FAK, JNK1, JNK2, and Kit.A potent and selective monopolar spindle 1 (Mps1) kinase inhibitor.

AZ3146 is a potent and selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 35 nM): less potent to FAK, JNK1, JNK2, and Kit.A potent and selective monopolar spindle 1 (Mps1) kinase inhibitor.

AZ3146 is a potent and selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 35 nM): less potent to FAK, JNK1, JNK2, and Kit.A potent and selective monopolar spindle 1 (Mps1) kinase inhibitor.

AZ3146 is a potent and selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 35 nM): less potent to FAK, JNK1, JNK2, and Kit.A potent and selective monopolar spindle 1 (Mps1) kinase inhibitor.

application：AZ3451 has been used as a protease-activated receptor 2 (PAR-2) antagonist to study the involvement of PAR-2 receptors in factor X activated (FXa)-induced upregulation of the cell adhesion molecules.

application：AZ3451 has been used as a protease-activated receptor 2 (PAR-2) antagonist to study the involvement of PAR-2 receptors in factor X activated (FXa)-induced upregulation of the cell adhesion molecules.

application：AZ3451 has been used as a protease-activated receptor 2 (PAR-2) antagonist to study the involvement of PAR-2 receptors in factor X activated (FXa)-induced upregulation of the cell adhesion molecules.

application：AZ3451 has been used as a protease-activated receptor 2 (PAR-2) antagonist to study the involvement of PAR-2 receptors in factor X activated (FXa)-induced upregulation of the cell adhesion molecules.